Taylor Automotive Family’s $1 Million Gift Helps Launch Taylor Cancer Research Center | The Blade

A transformational donation is helping bring innovative precision cancer research and clinical trial access to patients in Northwest Ohio.

The launch of Taylor Cancer Research Center marks an important step forward for cancer care in Northwest Ohio. Announced in January 2024, the new clinical research program was created through a $1 million donation from the Taylor Automotive family and is housed within Toledo Clinic Cancer Centers in Maumee. The new center was established to expand access to groundbreaking clinical trials and innovative cancer treatments that were not previously available in the region.

This effort is deeply personal for the Taylor family. The center also serves as a tribute to Julie Taylor, who battled multiple myeloma and received care through Toledo Clinic Cancer Centers. Her experience, and the burden of traveling outside the region for some treatments, helped inspire the family’s commitment to bringing more advanced cancer care closer to home.

Bringing Precision Therapy to Northwest Ohio

Taylor Cancer Research Center was founded to help patients access precision therapy, an approach to cancer treatment that targets the specific molecular or genetic drivers of a person’s disease. According to Toledo Clinic Cancer Centers, this work is designed to continue and expand research into precision-based treatments for patients in Northwest Ohio.

The Center’s mission is to implement a nationally acclaimed precision therapy program that expands research opportunities for cancer patients in Northwest Ohio and beyond. That mission reflects a broader goal of making leading-edge treatment options available locally, rather than requiring patients and families to travel to larger cities for specialized care.

A Vision Rooted in Gratitude and Community

Steve Taylor shared that the family’s gift was meant both to honor Julie’s generous spirit and to show appreciation for the care she received during her cancer journey. He also emphasized the importance of giving back to the Northwest Ohio community. Toledo Clinic’s announcement notes that the family saw an opportunity to help bring the same kind of precision-driven therapies available in major cities to Toledo and the surrounding region.

The family’s broader vision was not only to support one facility, but to help create something that would benefit cancer patients throughout the area. The Center was established as a not-for-profit clinical research program intended to expand treatment possibilities for patients across Northwest Ohio.

Leadership in Research and Clinical Innovation

A key part of the Center’s development is the involvement of Dr. John Nemunaitis, a nationally recognized leader in precision medicine and cancer research. Public reports describe him as an expert in precision therapy and clinical trial development whose experience helped shape the vision for bringing this work to Toledo.

Toledo Clinic leadership also emphasized that the goal is to expand the current clinical trial research program so patients in the Toledo region can receive nationally acclaimed therapy close to home. The program is designed to welcome participation from patients across the area and support collaboration with other regional cancer centers.

Why This Matters for Patients

For many families, access matters just as much as innovation. This new center represents more than a generous donation. It reflects a commitment to reducing barriers, expanding local treatment options, and helping patients participate in advanced clinical research without leaving the region.

By investing in precision therapy infrastructure and research, the Taylor Automotive family helped launch a program with the potential to reshape how cancer patients in Northwest Ohio access care, clinical trials, and personalized treatment.

Looking Ahead

Taylor Cancer Research Center continues to build on that founding vision: bringing innovative, research-driven cancer care closer to home. Its story begins with philanthropy, gratitude, and community leadership, but its long-term impact will be measured in the opportunities it creates for patients and families across the region.

Thank you The Blade.